LouisianaPHARMACEUTICALS: Requests a legislative auditor report on opioid settlement fund expenditures.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
Looking ahead
No hearings or votes scheduled.
History
- 2026
- May 20Sent to the Secretary of State by the Secretary of the Senate.Latest
- May 19Enrolled. Signed by the President of the Senate.Minor
- May 19Signed by the Speaker of the House.
- May 18Amendments proposed by the House read and concurred in by a vote of 35 yeas and 0 nays.
- Vote recorded CONCUR (#886). Result: pass.Upper
- May 13Read by title, amended, concurred in by vote of 81 yeas, 0 nays.
- Vote recorded FINAL CONSIDERATION (#1216). Result: pass.Lower
- May 13Received from the House with amendments.Minor
- May 12Scheduled for floor debate on 05/13/2026.
- May 5Read by title, passed to 3rd reading.Minor
- Apr 29Reported favorably (11-0).Minor
- Apr 14Read by title, under the rules, referred to the Committee on Health and Welfare.Minor
- Apr 13Read by title and adopted by a vote of 38 yeas and 0 nays. Ordered sent to the House.Passed 1st Chamber
- Vote recorded ADOPT (#296). Result: pass.Upper
- Apr 13Received in the House from the Senate.
- Apr 13Read by title. Lies over under the rules.
- Apr 8Reported favorably.Minor
- Mar 31Read second time by title and referred to the Committee on Health and Welfare.Minor
- Mar 30Introduced in the Senate. Read by title and placed on the Calendar for a second reading.Introduced